- Filed
- Feb 11, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Feb 1, 2022 | 42.41M sh |
| Capex | Q1 2022 · Dec 31, 2021 | $2.17M |
| Capex restated | Q1 2022 · Dec 31, 2020 | $2.61M |
| Operating Cash Flow | Q1 2022 · Dec 31, 2021 | −$2.68M |
| Operating Cash Flow | Q1 2022 · Dec 31, 2020 | $3M |
| Long Term Debt | Q1 2022 · Dec 31, 2021 | $110.65M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $2.07M |
| Cash And Equivalents | Q1 2022 · Sep 30, 2021 | $2.28M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2020 | $2.58M |
| Cash And Equivalents | Q1 2022 · Sep 30, 2020 | $6.05M |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | $3.23M |
| Stockholders Equity | Q1 2022 · Sep 30, 2021 | $12.58M |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | $14.99M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $54.86M |
| Current Liabilities | Q1 2022 · Sep 30, 2021 | $58.93M |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $196.38M |
| Total Liabilities | Q1 2022 · Sep 30, 2021 | $202.08M |
| Current Assets | Q1 2022 · Dec 31, 2021 | $78.4M |
| Current Assets | Q1 2022 · Sep 30, 2021 | $89.4M |
| Total Assets | Q1 2022 · Dec 31, 2021 | $199.61M |
| Total Assets | Q1 2022 · Sep 30, 2021 | $214.65M |
| Sga Expense | Q1 2022 · Dec 31, 2021 | $20.18M |
| Sga Expense restated | Q1 2022 · Dec 31, 2020 | $17.06M |
| Net Income | Q1 2022 · Dec 31, 2021 | −$9.39M |
| Net Income | Q1 2022 · Dec 31, 2020 | −$2.09M |
| Operating Income | Q1 2022 · Dec 31, 2021 | −$6.29M |
| Operating Income restated | Q1 2022 · Dec 31, 2020 | $990K |
| Cost Of Revenue | Q1 2022 · Dec 31, 2021 | $89.16M |
| Cost Of Revenue restated | Q1 2022 · Dec 31, 2020 | $93.16M |
| Revenue | Q1 2022 · Dec 31, 2021 | $103.08M |
| Revenue restated | Q1 2022 · Dec 31, 2020 | $111.14M |